May 2025 in “International Journal of Trichology” This prospective study reported that 5 mg daily oral low-dose minoxidil over 24 weeks led to a high prevalence of hypertrichosis in 93% of male androgenetic alopecia patients, particularly affecting younger individuals, but generally had minimal impact on patients’ quality of life.
March 2025 in “Pakistan journal of physiology.” This hospital-based cross-sectional study found that a substantial proportion of women with female pattern hair loss also had metabolic syndrome, with no significant differences in frequency across age, disease duration, or hair loss pattern subgroups.
March 2025 in “Forum Dermatologicum” This case report highlights the importance of trichoscopy in diagnosing fibrosing alopecia in pattern distribution, distinguishing it from female pattern hair loss, and guiding effective treatment.
This study observed that a combination treatment of 2% topical minoxidil and oral vitamin D significantly improved hair density and vitamin D levels in women with female pattern hair loss, compared to minoxidil or vitamin D used alone.
December 2024 in “International Journal For Multidisciplinary Research” This study found that monotherapy and topical medications are primarily used to treat pediatric skin diseases, with a variety of drugs prescribed indicating the complexity of these conditions.
September 2024 in “Frontiers in Genetics” In this study, researchers found a significant association between the rs13405699 SNP at 2q31.1 and male pattern baldness among Han Chinese men, suggesting genetic influence on this condition in this population.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
September 2024 in “Journal of the American Academy of Dermatology” This study found that estetrol (E4) significantly prolonged the anagen phase and increased hair matrix keratinocyte proliferation in cultured human hair follicles, suggesting its potential as a treatment for female pattern hair loss.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
May 2024 in “Dermatologic surgery” In this study involving 15 women with alopecia, subcutaneous scalp injections of platelet-rich plasma every four weeks for three sessions led to increased hair and hair follicle density at 24 weeks, with common side effects being local swelling and pain.
March 2024 in “Middle East Fertility Society Journal/Middle East Fertility Society Journal ” In this study, the researchers used dual-energy X-ray absorptiometry and found that women with polycystic ovary syndrome exhibit a central fat distribution pattern despite not having increased overall fat compared to controls, suggesting this method's potential utility in diagnosing and monitoring PCOS.
January 2024 in “Research Square (Research Square)” This study identified robust susceptibility genes and potential drug candidates for male-pattern baldness, providing insights into the condition's molecular mechanisms.
January 2024 in “Annals of Dermatology” In this retrospective study, 88.2% of women with female-pattern hair loss who underwent hair transplantation reported more than 75% satisfaction, with higher satisfaction noted in those receiving the most implants; however, complications such as pain and scarring were also observed.
December 2023 in “JEADV Clinical Practice” In this report, a young Caucasian woman developed a hairy tongue as an unusual side effect during baricitinib therapy for severe alopecia areata, which was managed by daily toothbrush debridement.
November 2023 in “International Journal of Dermatology” In this study, researchers analyzed histopathologic findings in 32 women with chronic diffuse alopecia and found that 40.6% had androgenetic alopecia, while a diffuse variant of lichen planopilaris was diagnosed in 32.5% of cases, emphasizing the importance of histopathologic examination for accurate diagnosis.
August 2023 in “Journal of Cosmetic Dermatology” This study found that combining minoxidil and spironolactone was more effective for hair density and severity of hair loss in women with androgenic alopecia compared to minoxidil and finasteride, with no serious adverse effects reported.
January 2023 in “Journal of Clinical and Diagnostic Research” This study in Chennai, India, found that while some trichoscopic patterns are specific, many overlap across different scalp dermatoses, highlighting the importance of dermatologists staying informed about the latest findings.
In this study conducted at a Pakistani hospital, skin diseases accounted for 5.5% of outpatient cases, with infections, scabies, and eczema being the most common conditions observed.
October 2020 in “Indian Journal of Forensic Medicine & Toxicology” This study examined the fingerprint patterns of students aged 18 to 28 from Raichur district but reports no new analytical outcomes or conclusions.
August 2020 in “Pakistan Journal of Zoology” This study identified a novel genetic mutation, c.429delC in the hairless gene, associated with atrichia with papular lesions in two Pakistani families.
September 2019 in “IP Indian journal of clinical and experimental dermatology” This study reported that in women with pattern baldness, hormonal levels and iron deficiency were significantly associated with the condition, but trichoscopic findings were similar across different forms of female pattern hair loss.
January 2018 in “프로그램북(구 초록집)” In this study, 24 weeks of using Scalpoo® shampoo, containing ingredients like biotin and herbal compounds, significantly reduced hair shedding by 43.6% and increased hair thickness and count in patients with male and female pattern hair loss, as assessed by imaging and expert evaluations.
January 2018 in “프로그램북(구 초록집)” In this study, intradermal injection of botulinum toxin type A significantly increased hair count and improved physician-assessed hair condition in men with male pattern baldness after 24 weeks, with no serious adverse events reported beyond temporary local pain and redness.
January 2016 in “프로그램북(구 초록집)” This study found that the revised BASP classification for pattern hair loss, which addresses certain limitations of the original, could serve as an alternative option despite a decrease in clinical accuracy and ease of use.
April 2012 in “Informa Healthcare eBooks” Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.
May 2004 in “Dermatologic Surgery” In this study, 32% of men continued taking finasteride for androgenetic alopecia after 1 to 3 years, but only a small percentage reported hair growth.
May 2025 in “Journal of Investigative Medicine” This study concluded that the Free Androgen Index (FAI) could serve as a reliable biomarker for hyperandrogenism in women with androgenetic alopecia, showing more predictive value than testosterone or SHBG alone.
October 2024 in “Clinical and Experimental Dermatology” This study found that combining 17α-estradiol 0.01% with minoxidil 2% offered no statistically significant advantage over minoxidil alone for treating female pattern hair loss and may increase the risk of menstrual irregularities.
January 2023 in “Pakistan Journal of Medical and Health Sciences” This study found that infections and infestations were the most common skin disorders among patients at the Bahawal Victoria Hospital's dermatology outpatient department.
May 2021 in “Pakistan Journal of Medical and Health Sciences” This study found that among Pakistani men with hair loss, the M type pattern was the most prevalent according to BASP classification.